The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: The FDA announced sotrovimab is no longer authorized to treat COVID-19 in any U.S. region due to increases in the proportion of COVID-19 cases caused by the...
READ MORE




